Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.

Kimberly A Burkhard, Fengming Chen, Paul Shapiro
Author Information
  1. Kimberly A Burkhard: Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA.

Abstract

Extracellular signal-regulated kinase-1 and -2 (ERK1/2) proteins regulate a variety of cellular functions, including cell proliferation and differentiation, by interacting with and phosphorylating substrate proteins. Two docking sites, common docking (CD/ED) domain and F-site recruitment site (FRS), on ERK proteins have been identified. Specific interactions with the CD/ED domain and the FRS occur with substrates containing a docking site for ERK and JNK, LXL (DEJL) motif (D-domain) and a docking site for ERK, FXF (DEF) motif (F-site), respectively. However, the relative contributions of the ERK docking sites in mediating substrate interactions that allow efficient phosphate transfer are largely unknown. In these studies, we provide a quantitative analysis of ERK2 interactions with substrates using surface plasmon resonance to measure real time protein-protein interactions. ERK2 interacted with ELK-1 (DEF and DEJL motifs), RSK-1 (DEJL motif), and c-Fos (DEF motif) with K(D) values of 0.25, 0.15, and 0.97 μM, respectively. CD/ED domain mutations inhibited interactions with ELK-1 and RSK-1 by 6-fold but had no effect on interactions with c-Fos. Select mutations in FRS residues differentially inhibited ELK-1 or c-Fos interactions with ERK2 but had little effect on RSK-1 interactions. Mutations in both the ED and FRS docking sites completely inhibited ELK-1 interactions but had no effect on interactions with stathmin, an ERK substrate whose docking site is unknown. The phosphorylation status of ERK2 did not affect interactions with RSK-1 or c-Fos but did inhibit interactions with ELK-1 and stathmin. These studies provide a quantitative evaluation of specific docking domains involved in mediating interactions between ERK2 and protein substrates and define the contributions of these interactions to phosphate transfer.

References

Mol Cell. 2004 Apr 9;14(1):43-55 [PMID: 15068802]
Cell. 1997 Sep 5;90(5):859-69 [PMID: 9298898]
Biophys J. 2004 Jan;86(1 Pt 1):395-403 [PMID: 14695281]
Biochim Biophys Acta. 2007 Aug;1773(8):1263-84 [PMID: 17126425]
J Biol Chem. 2001 Mar 2;276(9):6506-15 [PMID: 11104775]
Biochemistry. 2007 Aug 14;46(32):9187-98 [PMID: 17658892]
J Biol Chem. 2006 Mar 31;281(13):8917-26 [PMID: 16418172]
J Biol Chem. 2000 Jun 2;275(22):16609-17 [PMID: 10828059]
J Biol Chem. 2001 Jan 12;276(2):965-73 [PMID: 11029469]
Curr Opin Cell Biol. 1991 Dec;3(6):1025-32 [PMID: 1667578]
Mol Cell Biol. 1999 May;19(5):3551-60 [PMID: 10207078]
J Biol Chem. 2008 Apr 25;283(17):11176-88 [PMID: 18268018]
Mol Cell Biol. 1998 Feb;18(2):710-20 [PMID: 9447967]
Science. 2003 Apr 18;300(5618):445-52 [PMID: 12702867]
Endocr Rev. 2001 Apr;22(2):153-83 [PMID: 11294822]
Biochim Biophys Acta. 2005 Dec 30;1754(1-2):316-23 [PMID: 16324895]
Biochem Biophys Res Commun. 2009 Sep 18;387(2):414-8 [PMID: 19615338]
Biochim Biophys Acta. 2008 Jan;1784(1):48-55 [PMID: 18068683]
J Biol Chem. 1999 Jul 30;274(31):21900-7 [PMID: 10419510]
Biochem J. 2003 May 15;372(Pt 1):193-201 [PMID: 12583813]
Biochem J. 1994 Jun 1;300 ( Pt 2):331-8 [PMID: 8002936]
Mol Biotechnol. 2005 Jan;29(1):57-74 [PMID: 15668520]
Biochem J. 2003 May 15;372(Pt 1):1-13 [PMID: 12600273]
EMBO J. 1995 Oct 16;14(20):5048-59 [PMID: 7588633]
Nat Cell Biol. 2000 Feb;2(2):110-6 [PMID: 10655591]
Mol Cell Biol. 2003 Oct;23(19):7030-43 [PMID: 12972619]
Nat Struct Mol Biol. 2009 Oct;16(10):1004-5 [PMID: 19809488]
J Biol Chem. 2008 Feb 15;283(7):3854-65 [PMID: 18083711]
Methods. 2001 Jun;24(2):181-90 [PMID: 11384193]
J Biol Chem. 2006 Sep 1;281(35):25601-11 [PMID: 16799155]
Oncogene. 2007 May 14;26(22):3291-310 [PMID: 17496923]
Curr Opin Investig Drugs. 2008 Jun;9(6):614-30 [PMID: 18516761]
Growth Factors. 2006 Mar;24(1):21-44 [PMID: 16393692]
Oncogene. 1996 Apr 4;12(7):1493-502 [PMID: 8622865]
Curr Biol. 1999 Jul 29-Aug 12;9(15):810-20 [PMID: 10469565]
Nat Rev Mol Cell Biol. 2005 Nov;6(11):827-37 [PMID: 16227978]
J Biol Chem. 2002 Mar 22;277(12):9896-903 [PMID: 11786537]
Genes Dev. 1999 Jan 15;13(2):163-75 [PMID: 9925641]
Curr Biol. 1999 Mar 11;9(5):281-4 [PMID: 10074458]
J Biol Chem. 2008 Jul 11;283(28):19511-20 [PMID: 18482985]
Clin Cancer Res. 2008 Jan 15;14(2):342-6 [PMID: 18223206]
EMBO J. 2001 Feb 1;20(3):466-79 [PMID: 11157753]
J Biol Chem. 2009 Nov 27;284(48):33006-18 [PMID: 19805545]
Trends Biochem Sci. 1996 Dec;21(12):458-60 [PMID: 9009825]
Biochem Soc Trans. 2006 Nov;34(Pt 5):837-41 [PMID: 17052210]
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10952-6 [PMID: 8248197]
Curr Biol. 2005 Jul 26;15(14):1319-24 [PMID: 16051177]
Trends Biochem Sci. 2000 Sep;25(9):448-53 [PMID: 10973059]
J Biol Chem. 1998 Aug 28;273(35):22848-55 [PMID: 9712920]
Structure. 2006 Jun;14(6):1011-9 [PMID: 16765894]
J Biol Chem. 2005 May 6;280(18):17657-63 [PMID: 15728578]
Nat Cell Biol. 2002 Aug;4(8):556-64 [PMID: 12134156]
Nucleic Acids Res. 2001 Oct 15;29(20):E98 [PMID: 11600717]
J Biol Chem. 1999 Jan 29;274(5):2893-8 [PMID: 9915826]
J Biol Chem. 2001 Jul 20;276(29):27256-65 [PMID: 11371562]

Grants

  1. R01 CA120215/NCI NIH HHS
  2. CA120215/NCI NIH HHS

MeSH Term

Amino Acid Motifs
Binding Sites
Humans
Mitogen-Activated Protein Kinase 1
Mutation
Phosphorylation
Recombinant Proteins
Ribosomal Protein S6 Kinases, 90-kDa
Stathmin
Surface Plasmon Resonance
ets-Domain Protein Elk-1

Chemicals

ELK1 protein, human
Recombinant Proteins
STMN1 protein, human
Stathmin
ets-Domain Protein Elk-1
RPS6KA1 protein, human
Ribosomal Protein S6 Kinases, 90-kDa
MAPK1 protein, human
Mitogen-Activated Protein Kinase 1

Word Cloud

Similar Articles

Cited By